View in EDS

GLP-1 and amylin receptor multiagonism with amycretin for obesity management.

Saved in:
Bibliographic Details
Title: GLP-1 and amylin receptor multiagonism with amycretin for obesity management.
Authors: Khoo B; Endocrinology, Division of Medicine, University College London, London, UK., Tan TM; Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0HS, UK. Electronic address: t.tan@imperial.ac.uk.
Source: Lancet (London, England) [Lancet] 2025 Jul 12; Vol. 406 (10499), pp. 104-106. Date of Electronic Publication: 2025 Jun 20.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40550232
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: GLP-1 and amylin receptor multiagonism with amycretin for obesity management.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Khoo+B%22">Khoo B</searchLink>; Endocrinology, Division of Medicine, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Tan+TM%22">Tan TM</searchLink>; Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0HS, UK. Electronic address: t.tan@imperial.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2025 Jul 12; Vol. 406 (10499), pp. 104-106. <i>Date of Electronic Publication: </i>2025 Jun 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40550232
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0140-6736(25)01250-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104
    Titles:
      – TitleFull: GLP-1 and amylin receptor multiagonism with amycretin for obesity management.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Khoo B
      – PersonEntity:
          Name:
            NameFull: Tan TM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 07
              Text: 2025 Jul 12
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1474-547X
          Numbering:
            – Type: volume
              Value: 406
            – Type: issue
              Value: 10499
          Titles:
            – TitleFull: Lancet (London, England)
              Type: main
ResultId 1